BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1325543)

  • 1. Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system.
    Wang HC; Ho YS
    J Neurooncol; 1992 Jul; 13(3):265-76. PubMed ID: 1325543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading of astrocytomas. A simple and reproducible method.
    Daumas-Duport C; Scheithauer B; O'Fallon J; Kelly P
    Cancer; 1988 Nov; 62(10):2152-65. PubMed ID: 3179928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of survival and the Daumas-Duport grading system for astrocytomas.
    Kim TS; Halliday AL; Hedley-Whyte ET; Convery K
    J Neurosurg; 1991 Jan; 74(1):27-37. PubMed ID: 1984503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular proliferation in pilocytic and diffuse astrocytomas.
    Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
    J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignancy grading of glial tumors. I. Astrocytomas].
    Martin H; Schmidt D
    Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading astrocytomas.
    Adelman LS
    Neurosurg Clin N Am; 1994 Jan; 5(1):35-41. PubMed ID: 8124092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical study of proliferation index of astrocytomas classified by new histopathological grading].
    Takekawa Y; Sawada T; Sakurai I
    Rinsho Byori; 1995 May; 43(5):483-6. PubMed ID: 7783368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients.
    Forsyth PA; Shaw EG; Scheithauer BW; O'Fallon JR; Layton DD; Katzmann JA
    Cancer; 1993 Aug; 72(4):1335-42. PubMed ID: 8339223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of urokinase-type plasminogen activator in human gliomas.
    Hsu DW; Efird JT; Hedley-Whyte ET
    Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases.
    Labrousse F; Daumas-Duport C; Batorski L; Hoshino T
    J Neurosurg; 1991 Aug; 75(2):202-5. PubMed ID: 1649271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful?
    Bernhardtsen T; Laursen H; Bojsen-Møller M; Gjerris F
    Childs Nerv Syst; 2003 Nov; 19(10-11):729-35. PubMed ID: 14631523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Grading of astrocytomas and oligodendrogliomas].
    Kolles H; Niedermayer I; Feiden W
    Pathologe; 1998 Jul; 19(4):259-68. PubMed ID: 9746910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of volumetric tumor doubling time, DNA ploidy, and histologic grade on the survival of patients with intracranial astrocytomas.
    Blankenberg FG; Teplitz RL; Ellis W; Salamat MS; Min BH; Hall L; Boothroyd DB; Johnstone IM; Enzmann DR
    AJNR Am J Neuroradiol; 1995 May; 16(5):1001-12. PubMed ID: 7639120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.
    Sallinen PK; Sallinen SL; Helén PT; Rantala IS; Rautiainen E; Helin HJ; Kalimo H; Haapasalo HK
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):319-31. PubMed ID: 10931365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
    Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
    APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrosis as a prognostic factor in glioblastoma multiforme.
    Barker FG; Davis RL; Chang SM; Prados MD
    Cancer; 1996 Mar; 77(6):1161-6. PubMed ID: 8635139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors.
    Brown WD; Gilles FH; Tavaré CJ; Rorke LB; Davis RL; Adelman L; Hedley-Whyte ET; Leviton A
    J Neuropathol Exp Neurol; 1998 Nov; 57(11):1035-40. PubMed ID: 9825940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low grade supratentorial astrocytomas. Management and prognostic factors.
    Janny P; Cure H; Mohr M; Heldt N; Kwiatkowski F; Lemaire JJ; Plagne R; Rozan R
    Cancer; 1994 Apr; 73(7):1937-45. PubMed ID: 8137221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year survival and clinical prognostic factors in progressive supratentorial diffuse "low-grade" astrocytoma: a retrospective analysis of 46 cases.
    Schuurman PR; Troost D; Verbeeten B; Bosch DA
    Acta Neurochir (Wien); 1997; 139(1):2-7. PubMed ID: 9059704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.